NCT00126698

Prophylactic Antibiotics on Urethral Catheter Withdrawal

Use of Antibiotic Prophylaxis on Urethral Catheter Withdrawal: A Randomized Double-Blind Placebo-Controlled Trial

• Status: Completed
• Phase: Phase 4
• Study type: Interventional
• Enrollment: 100 (planned)
• Sponsor: St. Antonius Hospital · Academic / Other
• Sex: All
• Age: 18 Years
• Healthy volunteers: Not accepted

Summary

Urinary-tract infection (UTI) is the most common type of hospital-acquired infection (30% of all). The purpose of this study is to determine whether antibiotic prophylaxis for urinary catheter removal is useful at preventing catheter-associated urinary-tract infection.

Detailed description

Urinary-tract infection (UTI) is the most common type of hospital-acquired infection (30% of all). The researchers undertake a double-blind, placebo-controlled trial to assess the efficacy of single-dose therapy of trimethoprim-sulfamethoxazole or ciprofloxacin, versus placebo therapy in selected groups of surgical patients who had bladder drainage scheduled to last longer than 3 days.

Conditions

• Urinary Tract Infection
• Bacteriuria

Interventions

Type	Name	Description
DRUG	trimethoprim-sulfamethoxazole
DRUG	ciprofloxacin

Timeline

• Start date: 2005-01-01
• Completion: 2007-04-01
• First posted: 2005-08-04
• Last updated: 2007-04-19

Locations

1 site across 1 country: Netherlands